Last reviewed · How we verify

NCT03702205

Betaine Effect in Speed-strength Athletes

Status unknown Phase 2, PHASE3 Last updated 16 September 2020
What this trial tests

Phase 2, PHASE3 trial testing Betaine supplementation in Supplementation in 80 participants. Status unknown.

Timeline
15 October 2018
Primary endpoint
20 June 2021
12 October 2021

Quick facts

Lead sponsorPoznan University of Life Sciences
PhasePhase 2, PHASE3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposetreatment
Enrollment80
Start date15 October 2018
Primary completion20 June 2021
Estimated completion12 October 2021
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Poznan University of Life Sciences

Who can join

Adults 18 to 35, male only, with Supplementation or Sport. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is aimed at assessing the influence of two betaine doses (2.5 g∙d-1 and 5 g∙d-1) supplemented for three weeks in a group of speed-strength trained athletes on anaerobic capacity in Wingate test, performance in CrossFit-like exercise test - Fight Gone Bad, alterations in body compositions and total body water.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Betaine supplementation improves CrossFit performance and increases testosterone levels, but has no influence on Wingate power: randomized crossover trial.
    Zawieja E, Durkalec-Michalski K, Sadowski M, Główka N, et al · · 2023 · cited 4× · PMID 37409757 · DOI 10.1080/15502783.2023.2231411
  2. The Effect of 3-Week Betaine Supplementation on Blood Biomarkers of Cardiometabolic Health in Young Physically Active Males.
    Zawieja E, Durkalec-Michalski K, Muzsik-Kazimierska A, Chmurzynska A. · · 2022 · cited 3× · PMID 36005603 · DOI 10.3390/metabo12080731

Verify or expand the search:

Other recruiting trials for Supplementation

Currently open trials in the same condition.

Other Poznan University of Life Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03702205.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing